Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Melanie Donnette"'
Autor:
Melanie Donnette, Loic Osanno, Madeleine Giocanti, Geoffroy Venton, Laure Farnault, Yael Berda-Haddad, Régis Costello, Solas Caroline, L.’Houcine Ouafik, Joseph Ciccolini, Raphaëlle Fanciullino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:231-238
Autor:
Melanie Donnette, Mourad Hamimed, Joseph Ciccolini, Guillaume Sicard, Florian Correard, Laure Farnault, L'Houcine Ouafik, Geoffroy Venton, Raphaelle Fanciullino
Azacitidine (Vidaza®, Aza) is a mainstay for treating acute myeloid leukemia (AML) in patients unfit for induction chemotherapy and other high risk myelodysplastic syndromes (MDS). Only half of patients usually respond and almost all patients will r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1bcfaa7121754121254f621334d09ca
https://doi.org/10.21203/rs.3.rs-2370370/v1
https://doi.org/10.21203/rs.3.rs-2370370/v1
Autor:
Henriette Bosson-Vanga, Nicolas Primas, Jean-François Franetich, Catherine Lavazec, Lina Gomez, Kutub Ashraf, Maurel Tefit, Valérie Soulard, Nathalie Dereuddre-Bosquet, Roger Le Grand, Mélanie Donnette, Romain Mustière, Nadia Amanzougaghene, Shahin Tajeri, Peggy Suzanne, Aurélie Malzert-Fréon, Sylvain Rault, Patrice Vanelle, Sébastien Hutter, Anita Cohen, Georges Snounou, Pierre Roques, Nadine Azas, Prisca Lagardère, Vincent Lisowski, Nicolas Masurier, Michel Nguyen, Lucie Paloque, Françoise Benoit-Vical, Pierre Verhaeghe, Dominique Mazier
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 2 (2021)
ABSTRACT Human malaria infection begins with a one-time asymptomatic liver stage followed by a cyclic symptomatic blood stage. For decades, the research for novel antimalarials focused on the high-throughput screening of molecules that only targeted
Externí odkaz:
https://doaj.org/article/b8042b3d70524640b19a2ebd49c5a820
Autor:
Raphaelle Fanciullino, Laure Farnault, Mélanie Donnette, Diane-Charlotte Imbs, Catherine Roche, Geoffroy Venton, Yael Berda-Haddad, Vadim Ivanov, Joseph Ciccolini, L'Houcine Ouafik, Bruno Lacarelle, Regis Costello
Publikováno v:
Blood Advances, Vol 2, Iss 5, Pp 462-469 (2018)
Abstract: Cytarabine (Ara-C) is the backbone of acute myeloid leukemia (AML) chemotherapy. Little is known about possible risk factors predictive for the frequent (ie, up to 16%) life-threatening or lethal toxicities caused by Ara-C. Ara-C is detoxif
Externí odkaz:
https://doaj.org/article/84fa2bbf99cc4db5a089006627f8586d